Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MNCs Against Pricing Structure Of National Basic Medicine System

This article was originally published in PharmAsia News

Executive Summary

R&D-based Pharmaceutical Association Committee, multinational pharma's mouthpiece in China, recently disclosed its proposal for the national health care reform plan opinion draft. RDPAC considers the plan, which designates certain enterprises to produce and market basic medicine, to go against the country's anti-monopoly principles. Local pharmaceutical industry associations hold the same view (PharmAsia News, Oct. 20, 2008). (Click here for more - Chinese language)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC067599

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel